Your browser doesn't support javascript.
loading
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients.
Lin, Kong-Ying; Lin, Zhi-Wen; Chen, Qing-Jing; Luo, Liu-Ping; Zhang, Jian-Xi; Chen, Jin-Hong; Wang, Kui; Tai, Sheng; Zhang, Zhi-Bo; Wang, Shi-Feng; Zhang, Jin-Yu; You, Wu-Yi; Wang, Bin; You, Peng-Hui; Lin, Ke-Can; Yang, Tian; Zeng, Yong-Yi.
Afiliación
  • Lin KY; Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, China.
  • Lin ZW; Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China.
  • Chen QJ; Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, China.
  • Luo LP; Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China.
  • Zhang JX; Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, China.
  • Chen JH; Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China.
  • Wang K; Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, China.
  • Tai S; Department of Hepatobiliary Surgery, Xiamen Hospital, Beijing University of Chinese Medicine, Xiamen, 361000, China.
  • Zhang ZB; Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Fudan University, Shanghai, 200000, China.
  • Wang SF; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University (Second Military Medical University), Shanghai, 200000, China.
  • Zhang JY; Department of Hepatopancreatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, Harbin, 150086, China.
  • You WY; Department of Hepatopancreatobiliary Surgery, First Affiliated Hospital of Fujian Medical University, Fuzhou, 350000, China.
  • Wang B; Department of Hepatopancreatobiliary Surgery, Ganzhou Fifth People's Hospital of Gannan Medical University, Ganzhou, 341000, China.
  • You PH; Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou, 350025, China.
  • Lin KC; Department of Radiation, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350000, China.
  • Yang T; Department of Pathology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350000, China.
  • Zeng YY; Biobank in Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350000, China.
Hepatol Int ; 17(6): 1477-1489, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37382760
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hepatol Int Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hepatol Int Año: 2023 Tipo del documento: Article País de afiliación: China